These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 11887252)

  • 1. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].
    Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H
    Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
    Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
    J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sjögren's syndrome diagnosed in pregnancy: a case report.
    Aslan E; Tarim E; Kilicdag E; Simsek E
    J Reprod Med; 2005 Jan; 50(1):67-70. PubMed ID: 15730179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.
    Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL
    Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful preventive treatment of congenital heart block during pregnancy in a woman with systemic lupus erythematosus and anti-Sjögren's syndrome A/Ro antibody.
    Yang CH; Chen JY; Lee SC; Luo SF
    J Microbiol Immunol Infect; 2005 Oct; 38(5):365-9. PubMed ID: 16211147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful therapeutic management of risk pregnancy in primary Sjögren syndrome with plasmapheresis and dexamethasone].
    Feist E; Dörner T; Wagenmann A; Chaoui R; Rohde W; Burmester GR; Hiepe F
    Z Rheumatol; 1996; 55(2):127-32. PubMed ID: 8686386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal lupus erythematosus with congenital heart block associated with maternal systemic lupus erythematosus.
    Houssiau FA; Lebacq EG
    Clin Rheumatol; 1986 Dec; 5(4):505-8. PubMed ID: 3816098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardiopathy diagnosed in utero in a mother with SS-A antibodies treated with plasmapheresis].
    Arroyave CM; Puente Ledezma F; Montiel Amoroso G; Martínez García AC
    Ginecol Obstet Mex; 1995 Mar; 63():134-7. PubMed ID: 7744295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital atrioventricular block and maternal autoimmune diseases].
    Herreman G; Sauvaget F; Généreau T; Galezowski N
    Ann Med Interne (Paris); 1990; 141(3):234-8. PubMed ID: 2369012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
    Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.